foxidrive
Retired Admin
Patients with advanced skin cancer will soon have affordable access to a promising new immune-based treatment, following its listing on the Pharmaceutical Benefits Scheme.
The Federal Government will invest $57 million to list breakthrough drug Keytruda on the PBS, to improve the lives of more than 1,000 patients.
Health Minister Sussan Ley said the drug currently cost patients $150,000 a year, but they would now pay about $38, or just over $6 for those on concession.
This drug was charged at $411 per day. How can they do that to sufferers of a disease?